RECENT NEWS

Researchers at the University of Oxford have unveiled a new blood test – powered by machine learning – which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.

Aignostics has announced research results for a new pathology foundation model developed in collaboration with Mayo Clinic Digital Pathology. The model, built in two months using 1.2 million diverse slide images from Mayo Clinic and Charité – Universitätsmedizin Berlin, establishes a new state-of-the-art for performance across more than twenty public benchmarks.

Revvity has announced a strategic agreement to commercialise an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, a life science company democratising access to advanced DNA and multi-omic sequencing solutions.

AI-enabled pathology solutions company Proscia more than doubled its growth in 2024, it has announced. The company enters 2025 having cemented its leadership position, with life sciences organisations and diagnostic laboratories increasingly deploying its Concentriq enterprise pathology platform to advance the next novel therapies and diagnostics.

Biofidelity, a leader in innovative genomic solutions, and contract research organisation CellCarta, have announced a strategic partnership agreement to utilise Biofidelity’s Aspyre Lung in global clinical trials.

South West London Pathology (SWLP) has celebrated the installation of new cutting-edge technology from Beckman Coulter at its Essential Services Laboratory at Croydon Hospital, creating one of the most modern, innovative, and efficient clinical blood science services in the country.

The Institute of Biomedical Science (IBMS) has published a response to the government’s newly published ‘Reforming elective care for patients’, saying that investing in diagnostic capacity, digital transformation, and a robust biomedical science workforce is essential to delivering faster, more equitable elective care for all.

Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning will be used to bring new diagnostics to NHS patients, thanks to a new partnership between University College London Hospitals NHS Foundation Trust (UCLH) and Guilford Street Laboratories (GSL).

Leica Biosystems has agreed to make a significant strategic investment in Indica Labs, the two pathology firms have announced. This partnership aims to accelerate AI-enabled companion diagnostics and will also create a new digital pathology platform.

Risks that can lead to errors in cancer diagnoses could be reduced, as just one benefit of high precision platelet counting technology, launched by international health technology company Mindray.

Diagnostics firm Geneoscopy has announced new funding of $105 million, led by Bio-Rad Laboratories, to support the launch of non-invasive colorectal cancer screening test ColoSense, and advance diagnostic innovations for inflammatory bowel disease.

University of Pittsburgh researchers uncovered a surprising link between Alzheimer’s disease and herpes simplex virus-1 (HSV-1), suggesting that viral infections may play a role in the disease.

Scientists at the Allen Institute have developed a new approach that keeps blood cells alive in deep freeze, with this new technique promising to expand the reach of cutting-edge single-cell technologies to underserved populations.

A recently published study shows that a new blood test combined with an AI tool can better predict if individual cancer patients will benefit from immune checkpoint inhibitors, a type of immunotherapy treatment.

The USA’s National Institute of Standards and Technology (NIST) has developed a synthetic, non-hazardous genetic material to support the development and validation of diagnostic tests for the H5N1 virus - commonly known as bird influenza.

Professor Anthony Harnden has taken up the position as Chair of the Medicine and Healthcare products Regulatory Agency (MHRA), from January 2025.

Prime Minister Sir Keir Starmer has unveiled the government’s Elective Reform Plan, which aims to end NHS backlogs by offering up to half a million more appointments each year thanks to greater access to Community Diagnostic Centres and new or expanded surgical hubs.

The Institute of Biomedical Science (IBMS) has announced Dr Sarah Pitt CSci FIBMS as its new President Elect, having taken office on 1 January to support Joanna Andrew in her second and final year as President.

The proportion of patients being diagnosed with cancer at an early stage in England has risen to its highest ever level, according to new NHS figures.

The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve brain health, has announced it will work with Janssen Research & Development, a Johnson & Johnson company, and Beckman Coulter Diagnostics, two leading pharmaceutical and diagnostics companies, to advance the assay validation of blood-based biomarkers for Alzheimer’s disease for global use in diverse populations.